Ganomycin I, ganomycin B, and ganomycin C exhibited superior inhibitory activity against HMG-CoA reductase compared to the positive control atorvastatin, with IC 50 values of 12.3 1.7, 29.3 2.5, and 45.2 7.1 M, respectively (Atorvastatin IC 50 = 32.1 7.7 M)
Medicare to start covering GLP-1 weight-loss therapies on July 1, 2026 May 2026 The Centers for Medicare & Medicaid Services (CMS) has launched the GLP-1 Bridge Program, a temporary initiative to provide coverage for effective weight-loss medications
It does not compete directly on maximum weight loss with injectable multi-receptor agonists but instead offers a differentiated value proposition based on oral convenience, no restrictions, lower manufacturing costs, and the potential to dramatically expand the addressable patient population for GLP-1 therapy
Mild allergic reactions (rash, itching, mild swelling) sometimes seen even with proper technique
Vitamin B12 is vital for DNA synthesis and methylation reactions (like DNA methylation), which impact gene expression, cellular function, and overall health
And so far Im happy with the product and this company